OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacological Reviews is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Seventy-Five Years of Interactions: The Department of Physiology and Pharmacology at Karolinska Institutet and Pharmacological Reviews	285
Innovative therapeutics for renoprotection: Where we are	221
The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes	208
Review of Natural Language Processing in Pharmacology	171
The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics	144
Reimagining pharmacology education	135
The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets	133
Table of Contents	131
Table of Contents	129
Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapies	123
Carbonic anhydrase inhibitors: “Old” drugs with new potential in unexpected areas	121
Metal-based antibody, nanobody, and peptide conjugates: Potential for breast cancer therapy	112
Mitochondrial metabolism as a pharmacological target for cancer therapeutics	110
Table of Contents	96
Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems	90
Targeting of kinases to treat neurodegenerative diseases	88
Optical Approaches for Investigating Neuromodulation and G Protein–Coupled Receptor Signaling	88
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023	75
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes	73
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer	72
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins	72
The Skeletal Connectome: From Molecular Circuitry to Systemic Network Medicine	71
Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases	71
Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications	69
Table of Contents	69

Therapeutic Potential of Targeting Prokineticin Receptors in Diseases	68
miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response	64
Asthma therapeutics: Past, present, and future	64
G Protein-Coupled Receptor Pharmacology—Insights from Mass Spectrometry	64
The Hippo pathway: Organ size control and beyond	62
Corrigendum to “International Union of Basic and Clinical Pharmacology. CXIX. Fundamental insights and clinical relevance regarding the carnitine palmitoyltransferase family of enzymes” [Pharmacologic	60
Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism	60
Sulfotransferase 2B1b, Sterol Sulfonation, and Disease	56
Nonhormonal Male Contraceptive Development—Strategies for Progress	56
From neuroimmune circuits to targeted therapy of chronic pruritus	55
Neurobiology of the incubation of drug craving: An update	55
Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood	54
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy	53
Kv7 channels as pharmacological targets for CNS diseases	49
Disulfidptosis: A novel cell death mechanism with pathological significance and therapeutic potential in diseases	47
Editorial Board	47
Dopamine, Immunity, and Disease	47
Pharmacological Reviews’ 75th Year Anniversary: Past and Future—Editorial	45
Extracellular Vesicle Heterogeneity and Its Impact for Regenerative Medicine Applications	43